-+ 0.00%
-+ 0.00%
-+ 0.00%
GoodRx names Chief Strategy and Operations Officer Justin Fengler as CFO, succeeding Christopher McGinnis
Share
Listen to the news
GoodRx names Chief Strategy and Operations Officer Justin Fengler as CFO, succeeding Christopher McGinnis
  • GoodRx named Chief Strategy & Operations Officer Justin Fengler as chief financial officer and treasurer, effective Aug. 6, 2026.
  • Christopher McGinnis will step down as CFO and treasurer at 11:59 p.m. ET on Aug. 5, 2026; departure not tied to disputes.
  • Fengler, 38, has served as chief strategy and operations officer since September 2025; he has been with the company since 2016.
  • He previously led corporate strategy and business operations from 2018; earlier roles included TripleTree investment banking, Oliver Wyman consulting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GoodRx Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001809519-26-000153), on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending